| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
63,988 |
60,837 |
$6.37M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
62,205 |
59,888 |
$4.40M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
20,163 |
19,897 |
$1.88M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,324 |
17,159 |
$1.59M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12,742 |
12,465 |
$1.11M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,784 |
8,700 |
$869K |
| 92552 |
|
33,690 |
33,222 |
$689K |
| 99499 |
|
21,606 |
21,248 |
$562K |
| 99429 |
|
17,944 |
17,618 |
$473K |
| 99215 |
Prolong outpt/office vis |
3,117 |
2,945 |
$448K |
| G9149 |
National committee for quality assurance - level 2 medical home |
1,453 |
1,436 |
$295K |
| 99051 |
|
10,036 |
9,816 |
$288K |
| D0120 |
Periodic oral evaluation - established patient |
11,467 |
11,196 |
$253K |
| D9999 |
Unspecified adjunctive procedure, by report |
11,123 |
10,852 |
$218K |
| 96127 |
|
62,528 |
50,695 |
$194K |
| 90686 |
|
11,311 |
11,219 |
$188K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,170 |
4,099 |
$174K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,232 |
4,152 |
$152K |
| 90688 |
|
9,338 |
9,206 |
$125K |
| 90670 |
|
7,737 |
7,673 |
$109K |
| D1206 |
Topical application of fluoride varnish |
6,932 |
6,791 |
$90K |
| 99174 |
|
6,120 |
6,048 |
$87K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,805 |
3,752 |
$84K |
| 99188 |
|
7,479 |
6,246 |
$83K |
| 90648 |
|
6,535 |
6,476 |
$83K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,293 |
3,110 |
$74K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,834 |
7,413 |
$71K |
| G9150 |
National committee for quality assurance - level 3 medical home |
756 |
754 |
$61K |
| 90680 |
|
3,477 |
3,429 |
$53K |
| 90723 |
|
3,524 |
3,503 |
$45K |
| 36416 |
|
12,525 |
12,026 |
$43K |
| 99173 |
|
26,548 |
26,258 |
$40K |
| 96160 |
|
19,237 |
18,895 |
$40K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,537 |
1,458 |
$38K |
| 99177 |
|
15,639 |
15,384 |
$34K |
| 83655 |
|
2,606 |
2,572 |
$33K |
| 90697 |
|
1,723 |
1,689 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,117 |
2,080 |
$32K |
| 90633 |
|
2,337 |
2,324 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,088 |
1,031 |
$32K |
| 90651 |
|
2,183 |
2,159 |
$30K |
| 85018 |
|
11,682 |
11,506 |
$28K |
| 90671 |
|
1,260 |
1,234 |
$26K |
| 80061 |
Lipid panel |
1,818 |
1,783 |
$24K |
| 0071A |
|
610 |
608 |
$23K |
| 99381 |
|
247 |
239 |
$23K |
| 0072A |
|
495 |
495 |
$19K |
| 99383 |
|
183 |
178 |
$19K |
| 90685 |
|
1,354 |
1,324 |
$17K |
| 90480 |
|
517 |
504 |
$16K |
| 96161 |
|
7,525 |
7,286 |
$13K |
| 0001A |
|
294 |
288 |
$11K |
| 90677 |
|
855 |
803 |
$10K |
| 0002A |
|
237 |
236 |
$9K |
| 90734 |
|
744 |
738 |
$9K |
| 99339 |
|
145 |
142 |
$8K |
| 90619 |
|
517 |
513 |
$8K |
| 99462 |
|
171 |
113 |
$5K |
| 90707 |
|
366 |
353 |
$5K |
| 99401 |
|
157 |
157 |
$5K |
| 90715 |
|
312 |
308 |
$5K |
| 90710 |
|
295 |
293 |
$4K |
| 99460 |
|
62 |
54 |
$4K |
| 99382 |
|
39 |
39 |
$4K |
| 90716 |
|
260 |
256 |
$4K |
| 0124A |
|
92 |
92 |
$4K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
107 |
98 |
$3K |
| 0154A |
|
81 |
81 |
$3K |
| 90700 |
|
202 |
201 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
559 |
534 |
$2K |
| 81003 |
|
961 |
919 |
$2K |
| 90696 |
|
115 |
114 |
$2K |
| 90661 |
|
889 |
872 |
$2K |
| 0003A |
|
48 |
48 |
$2K |
| 99001 |
|
115 |
112 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
28 |
27 |
$2K |
| 0073A |
|
37 |
37 |
$1K |
| 90656 |
|
435 |
435 |
$1K |
| 94060 |
|
26 |
25 |
$969.84 |
| 0081A |
|
24 |
24 |
$960.00 |
| 90474 |
|
71 |
66 |
$908.34 |
| 94664 |
|
73 |
73 |
$775.32 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
50 |
46 |
$563.35 |
| 0054A |
|
14 |
14 |
$560.00 |
| 87807 |
|
37 |
37 |
$496.99 |
| 84703 |
|
66 |
64 |
$468.60 |
| 99072 |
|
69,990 |
65,709 |
$133.42 |
| 91319 |
|
27 |
27 |
$39.51 |
| 91320 |
|
25 |
24 |
$31.44 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
40 |
$25.87 |
| 99000 |
|
9,826 |
9,116 |
$10.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
26 |
$0.45 |
| A4322 |
Irrigation syringe, bulb or piston, each |
16 |
15 |
$0.00 |
| 94150 |
|
25 |
24 |
$0.00 |